The device is a transcutaneous electrical nerve stimulator intended for the symptomatic relief and management of chronic intractable pain in the lower leg and foot. The device has FDA clearance and the company is planning a full launch during the first quarter of next year.
More Articles on Pain Management:
Dr. Vladimir Redko Joins North American Spine
Washington Center for Pain Management to Expand
Ameridose Recalls Products After FDA Investigation
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.